PA8649001A1 - Metodo de prevencion o tratamiento de infecciones respiratorias en infantes - Google Patents

Metodo de prevencion o tratamiento de infecciones respiratorias en infantes

Info

Publication number
PA8649001A1
PA8649001A1 PA20058649001A PA8649001A PA8649001A1 PA 8649001 A1 PA8649001 A1 PA 8649001A1 PA 20058649001 A PA20058649001 A PA 20058649001A PA 8649001 A PA8649001 A PA 8649001A PA 8649001 A1 PA8649001 A1 PA 8649001A1
Authority
PA
Panama
Prior art keywords
children
prevention
treatment
respiratory infections
dha
Prior art date
Application number
PA20058649001A
Other languages
English (en)
Inventor
Carlos H Lifschitz
Nitida Pastor
Original Assignee
Bristol Myers Squibb Company B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Company B filed Critical Bristol Myers Squibb Company B
Publication of PA8649001A1 publication Critical patent/PA8649001A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION ESTA DIRIGIDA A UN NUEVO METODO PARA LA PREVENCION O TRATAMIENTO DE INFECCIONES RESPIRATORIAS EN INFANTES. EL METODO COMPRENDE LA ADMINISTRACION DE UNA CANTIDAD EFECTIVA TERAPEUTICAMENTE DE DHA Y ARA AL INFANTE.
PA20058649001A 2005-04-07 2005-10-07 Metodo de prevencion o tratamiento de infecciones respiratorias en infantes PA8649001A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66911105P 2005-04-07 2005-04-07
US11/114,892 US20060229366A1 (en) 2005-04-07 2005-04-26 Method for preventing or treating respiratory infections in infants

Publications (1)

Publication Number Publication Date
PA8649001A1 true PA8649001A1 (es) 2006-10-13

Family

ID=35432875

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20058649001A PA8649001A1 (es) 2005-04-07 2005-10-07 Metodo de prevencion o tratamiento de infecciones respiratorias en infantes

Country Status (14)

Country Link
US (1) US20060229366A1 (es)
EP (1) EP1709961A1 (es)
KR (1) KR20060106583A (es)
AR (1) AR052641A1 (es)
BR (1) BRPI0503827A (es)
CA (1) CA2516873A1 (es)
CO (1) CO5750041A1 (es)
IN (1) IN2006CH00621A (es)
MX (1) MXPA05009927A (es)
NO (1) NO20055079L (es)
PA (1) PA8649001A1 (es)
RU (1) RU2005130292A (es)
SG (1) SG126810A1 (es)
TW (1) TW200635574A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
AU2008320328B2 (en) * 2007-11-01 2014-10-02 Frutarom Limited Lipid mixture for infant nutrition
WO2012012498A2 (en) * 2010-07-20 2012-01-26 Pulmatrix, Inc. Use of trp channel agonists to treat infections
RU2017144619A (ru) 2010-09-29 2019-02-20 Пулмэтрикс, Инк. Катионы одновалентных металлов сухих порошков для ингаляций
AU2014248455B2 (en) 2013-04-01 2018-12-06 Pulmatrix Operating Company, Inc. Tiotropium dry powders
WO2022226311A1 (en) * 2021-04-23 2022-10-27 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
BR9205526A (pt) 1991-01-24 1994-04-19 Martek Corp Sociedade Norte Am Misturas de oleos microbianos e usos dos mesmos
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
CA2284682A1 (en) * 1997-03-27 1998-10-15 Bristol-Myers Squibb Company Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
US6180671B1 (en) * 1998-03-10 2001-01-30 Beth Israel Deaconess Medical Center, Inc. Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
US20040143013A1 (en) * 2000-02-28 2004-07-22 Bristol-Myers Squibb Company Use of docosahexaenoic acid and arachidonic acid enhancing the growth of preterm infants
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält

Also Published As

Publication number Publication date
TW200635574A (en) 2006-10-16
CA2516873A1 (en) 2006-10-07
NO20055079D0 (no) 2005-10-31
SG126810A1 (en) 2006-11-29
BRPI0503827A (pt) 2006-12-19
RU2005130292A (ru) 2007-04-10
AR052641A1 (es) 2007-03-28
MXPA05009927A (es) 2006-10-01
IN2006CH00621A (es) 2007-06-15
CO5750041A1 (es) 2007-04-30
NO20055079L (no) 2006-10-09
KR20060106583A (ko) 2006-10-12
US20060229366A1 (en) 2006-10-12
EP1709961A1 (en) 2006-10-11

Similar Documents

Publication Publication Date Title
PA8649001A1 (es) Metodo de prevencion o tratamiento de infecciones respiratorias en infantes
EP2099449A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF DISEASES THAT COME WITH IMPOTENCE
ATE540690T1 (de) Insulinkombinationen
HK1137352A1 (en) Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent
GB2455625B (en) The use of benzoquinones and hydroquinones as antibacterial agents in the treatment of periodontal diseases
BRPI0922823A2 (pt) Combinações e modos de administração de agentes terapêuticos e terapia de combinação
CY2014023I1 (el) Συνδυασμοι και τροποι χορηγησης θεραπευτικων παραγοντων και θεραπεια συνδυασμου
EA200702358A1 (ru) Комбинация ингибитора pde4 и производного тетрагидробиоптерина
EA201101117A1 (ru) Ингибиторы дпп-4 для лечения диабета у детей
PL1799231T3 (pl) Zastosowanie cyklodekstryny do leczenia i zapobiegania chorobom zapalnym oskrzeli
BRPI0811111A2 (pt) composição farmacêutica oronasofaringeamente liberável para a prevenção/alívio e/ou tratamento do distúrbio de membros inquietos
EA200802208A1 (ru) Применение флибансерина для лечения расстройств полового влечения в постклимактерический период
EA021554B9 (ru) Органические соединения и их применение для лечения hcv инфекции
BRPI0606322A2 (pt) formulações intravenosas de inibidores de pde-5
CY2018006I2 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
EP1814567A4 (en) USE OF MODULATORS OF EPHA2 AND EPHRINA1 FOR TREATING AND PREVENTING INFECTIONS
HK1104460A1 (en) Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases
UA100702C2 (ru) Комбинационная терапия рака поджелудочной железы с использованием антигенного пептида и химиотерапевтического средства - гемцитабина
ECSP11011101A (es) Compuestos cicloundecadepsipéptidos y el uso de dichos compuestos como un medicamento
TW200724146A (en) Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
EP1930017A4 (en) EFFECTIVE COMPOSITION FOR THE PREVENTION AND TREATMENT OF PATHOLOGY IN THE ADULT
UY30675A1 (es) Metodos para el tratamiento de la depresion
BRPI0716137A2 (pt) Utilização de açúcares de c7 na prevenção e no tratamento de micoses
DOP2005000170A (es) Metodo de prevencion o tratamiento de infeciones respiratorias en infantes
EP2054080A4 (en) TREATMENT AND PREVENTION OF ALLERGIC RESPIRATORY DISEASES